Please enter a valid keyword with 2 or more characters / numbers.
Panacea Global, Inc. (PGI) is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. We have developed a blood test that can detect the presence of cancer in humans using a novel cancer biomarker named Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH), an enzyme which is over expressed in cancer cells and is the foundation of our breakthrough technology. PGI offers patients with highly accurate, reliable, fast and cost-effective cancer detection tests, which can be used for early diagnosis, remission and recurrence of cancer following treatment. PGI is currently at the stage of launching its products that includes diagnostics for breast, colon, prostate, and lung cancers, which make up over 80% of cases of cancer.